These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
Nadda also commended the role of ASHA workers, “grassroot foot soldiers”, in the healthcare system
This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain
Sarat Kumar has been appointed as CFO of the company and also designated as Key Managerial Personnel with effect from February 21, 2025
This Yearbook aims to distinguish those companies that have demonstrated strengths in corporate sustainability
International Meeting of World Pharmacopoeias serves as a vital platform to foster international collaboration in pharmacopoeial science and regulatory harmonization
EBITDA grew 46.9% YoY to Rs. 210.3 crore with EBITDA margin at 18.2%, grew 401 bps YoY and the reported PAT at Rs. 90 crore
Biocon’s subsidiary Biocon Biologics Limited, which also participated independently in the assessment for the first time, reported an S&P Global ESG Score of 53
Scored 85/100, 2.3x the industry average in Social and 73/100, 1.8x the industry average in Governance
Subscribe To Our Newsletter & Stay Updated
